The American Diabetes Association (ADA) is calling for makers of incretin therapies (which include Januvia and Byetta) to release all of their data on the drugs in an effort to clarify whether they have adverse effects on the pancreas.

The ADA wants the companies to make available all patient-level data on their products for an independent review “that could help settle the question of whether such therapies contribute to the development of pancreatitis or pancreatic cancer,” the organization said in a statement.

“People who are taking these medications, or who may consider taking them, should have the benefit of all that is currently known about their risks and advantages in order to make the best possible decisions about their treatment and care in consultation with their healthcare providers,” Robert Ratner, MD, chief scientific and medical officer of the ADA, said in a statement.

Read the whole story at Med Page Today

If you or a loved one developed pancreatic cancer or thyroid cancer after taking Januvia, Byetta, or another incretin mimetic,  you may be entitled to compensation through a diabetes drug lawsuit. Upton Law Firm’s experienced Januvia and Byetta lawyers can help assess your claim. Our representatives are always available for a free, no-obligation legal consultation. Fill out the form here, or call 877-675-7987 now to discuss your potential Januvia or Byetta lawsuit.

Bloomberg News

Merck & Co. (MRK), Novo Nordisk A/S (NOVOB) and other makers of popular treatments for diabetes may be asked to collect more data on a potential cancer link even as they try to reassure U.S. regulators this week of the drugs’ safety.

Read the whole story at Bloomberg News

If you or a loved one developed pancreatic cancer or thyroid cancer after taking Januvia, Byetta, or another incretin mimetic,  you may be entitled to compensation through a diabetes drug lawsuit. Upton Law Firm’s experienced Januvia and Byetta lawyers can help assess your claim. Our representatives are always available for a free, no-obligation legal consultation. Fill out the form here, or call 877-675-7987 now to discuss your potential Januvia or Byetta lawsuit.

The European Medicines Agency’s investigation comes on the heels of a similar probe by the U.S. FDA.

An academic research article published in the Diabetes journal has regulators concerned. The article suggests that an entire class of type 2 diabetes drugs called incretin mimetics may lead to an increased risk of pancreatic cancer. Earlier studies indicate a link between these drugs and thyroid cancer.

Incretin mimetic drugs include several widely popular medications, such as Byetta, Bydureon, Januvia, Janumet, and Victoza.

The Januvia and Byetta attorneys at Upton Law Firm believe there is evidence indicating that the manufacturers of these drugs knew of the cancer risk but failed to warn patients. If you or a loved one were injured by Januvia, Byetta, or another incretin mimetic, you may be entitled to compensation through a diabetes drug lawsuit. To begin your free legal consultation, call 1-877-675-7987 or complete the form available here.

In April, the FDA said it is evaluating Januvia and other drugs in the incretin mimetics class for possible links to cancer.

Dr. Peter C. Butler, chief of the division of endocrinology at the University of California Los Angeles, conducted the scientific research at the heart of the FDA’s Januvia warning.

The future of Januvia and other similar drugs, including Byetta, Bydureon, Victoza, and Janumet, is now in doubt.

The National Institutes of Health will review the possible links between diabetes drugs and pancreatic cancer later this month.

The product liability attorneys at Upton Law Firm are investigating possible Januvia cancer lawsuits as well as Byetta, Bydureon, Victoza, and Janumet lawsuits. Our attorneys are always available for a free, no-obligation legal consultation. Fill out the form here or call 1-877-675-7987.

U.S. District Judge Joseph R. Goodwin of the U.S. District Court for the Southern District of West Virginia found that the plaintiffs had established a question of fact as to whether the company’s actions rose to a level amounting to culpable behavior.

The judge concluded, “the mere inclusion of some warning with a product does not absolve the manufacturer of potential punitive damage liability . . ..”

The transvaginal and pelvic mesh attorneys at Upton Law Firm are investigating these unsafe products. If you or a loved one were injured by surgical mesh, you may be entitled to compensation through a pelvic mesh lawsuit. To begin your free legal consultation, call 1-877-675-7987 or complete the form available here.

Elizabeth Childress, who is only 23 years old, said in the complaint that she was diagnosed with thyroid cancer after using Byetta to treat diabetes.

According to the complaint, the manufacturers of Byetta, Amylin and Eli Lilly, knew about the link between the drug and thyroid cancer but failed to provide adequate warnings or issue a recall to withdraw Byetta from the market.

Childress seeks damages from Amylin and Eli Lilly for failure to warn, defective design, negligence, breach of warranty, negligent misrepresentation, and fraudulent concealment. Byetta has also been the subject of a number of pancreatic cancer lawsuits in recent months.

Byetta is an incretin mimetic diabetes drug. This class of medications also includes Januvia, Victoza, and a longer-acting version of Byetta known as Bydureon.

Upton Law Firm is investigating the relationship between diabetes drugs and cancer. If you or a loved one took a diabetes drug such Byetta, Januvia, Bydureon, or Victoza and later developed cancer, please contact us for a free consultation.

To speak with a Byetta lawyer now call 1-877-675-7987 or complete this free case review form.

Most of the plaintiffs claim injuries such as pancreatitis or pancreatic cancer, according to the latest quarterly regulatory filing from the manufacturer of Byetta, Bristol-Myers Squibb.

In addition, 43 lawsuits claim that Januvia caused pancreatic cancer, according to its manufacturer, Merck.

Januvia and Byetta belong to a class of drugs used to treat diabetes. Other drugs in the class, called incretin mimetics, are Bydureon and Onglyza, which are also sold by Bristol-Myers Squibb and AstraZeneca; Victoza from Novo Nordisk; Tradjenta from Eli Lilly and Boehringer Ingelheim; and Nesina from Takeda.

These drugs are widely used. Indeed, Januvia’s sales alone were over $5 billion just last year.

Upton Law Firm’s defective product attorneys are reviewing cases involving Januvia, Byetta, Bydureon, Onglyza, Victoza, Tradjenta, and Nesina.

If you or a loved one suffered pancreatic cancer or pancreatitis after taking Januvia, Byetta, or another incretin mimetic, contact us today at 877-675-7987 or by clicking here.

These women took Yasmin or Yaz for birth control and later suffered injuries relating to blood clots and deep vein thrombosis.

Each woman claims that the manufacturer of the drugs, Bayer Healthcare Pharmaceuticals, failed to warn about the serious side effects.

The women filed their joint  lawsuit in the U.S. District Court for the Southern District of Illinois, which is the site of consolidated proceedings against Bayer.

The complaint alleges Bayer concealed information from consumers that Yasmin and Yaz are potentially dangerous medications linked to an increased risk of blood clot injuries.

Each woman is seeking compensation for economic damages, noneconomic damages, and related medical costs.

The dangerous drug attorneys at Upton Law Firm are investigating Yaz and Yasmin injuries. If you or a loved on have been harmed by a birth control medication, contact us today at 877-675-7987 or click here.

This type of consolidation is referred to as Multidistrict Litigation or MDL.

Defense lawyers for the manufacturer of Effexor, Pfizer, recently filed a motion supporting an MDL for cases brought on behalf of children who suffered birth defects or malformations after their mothers used the antidepressant during pregnancy.

Both sides agree that the new MDL should be assigned to the judge who is handling all Zoloft birth defect lawsuits against Pfizer, which is another of the company’s antidepressants similar to Effexor.

The establishment of an MDL is common in complex litigation where a large number of complaints have been filed throughout the country involving similar allegations.

There are currently at least 14 cases pending in 7 different U.S. District Courts that allege Pfizer did not adequately warn about the effects that Effexor may have on unborn children. Given the widespread use of Effexor, hundreds of additional lawsuits are likely.

Oral arguments on the motion to centralize the Effexor birth defect lawsuits are scheduled for July 25, 2013 in Portland, Maine.

Upton Law Firm is investigating Effexor birth defects cases. If you or a loved one took Effexor while pregnant and gave birth to a child with a birth defect or malformation, you and your child may be entitled to compensation.

To speak with an Effexor lawyer, call (877) 675-7987 or click here.